Author

Karima Farrag 1

1 Interdisciplinary Crohn Colit

ASSOCIATION BETWEEN SERUM VITAMIN D METABOLITES AND HEMATOLOGICAL MARKERS OF INFLAMMATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Aysegül Aksan, Sami Aksan, Oliver Schröder, Luisa Röske, Karima Farrag, Jürgen Stein

DIAGNOSIS OF IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE: ARE FERRITIN AND CRP SUFFICIENT?

Karima Farrag

Diagnosis of iron deficiency in inflammatory bowel disease: are ferritin and CRP sufficient?

Karima Farrag, Valeza Ademaj-Kospiri, Irini Mavrommataki, Katharina Böttger, Aysegül Aksan, Eleni Leventi, Franz Paul Armbruster, Axel Dignass, Jürgen Stein

ENDOSCOPIC STENT PLACEMENT FOR TREATMENT OF SLEEVE GASTRECTOMY LEAK: A SINGLE INSTITUTION EXPERIENCE WITH FULLY-COVERED STENTS

Karima Farrag

Endoscopic stent placement for treatment of sleeve gastrectomy leak: a single institution experience with fully-covered stents

Karima Farrag, Irini Mavrommataki, Johanna Erbach, Lukas Altmann, Plamen Staikov, Jürgen Stein

IN CONTRAST TO FAECAL CALPROTECTIN (FC), INCREASED FAECAL APHA-1-ANTITRYPSIN (A1AT) EXCRETION IS ASSOCIATED WITH LOW THROUGH LEVELS IN PATIENTS WITH SEVERE ULCERATIVE COLITIS LACKING RESPONSE TO MONOCLONAL ANTIBODY (MAB) THERAPY

Karima Farrag, Aysegül Aksan, Oliver Schröder, Axel Dignass, Jürgen Stein

IN CONTRAST TO FAECAL CALPROTECTIN (FC), INCREASED FAECAL APHA-1-ANTITRYPSIN (A1AT) EXCRETION IS ASSOCIATED WITH LOW THROUGH LEVELS IN PATIENTS WITH SEVERE ULCERATIVE COLITIS LACKING RESPONSE TO MONOCLONAL ANTIBODY (MAB) THERAPY

Karima Farrag

IN CONTRAST TO ORAL IRON THERAPY, INTRAVENOUS IRON THERAPY IS NEITHER INFLUENCED BY, NOR DOES IT EXACERBATE, SYSTEMIC INFLAMMATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Aysegül Aksan, Jürgen Stein, Oliver Schröder, Axel Dignass, Karima Farrag

IS VITAMIN D DEFICIENCY RELATED TO FAT MALABSORPTION OR INFLAMMATION IN INFLAMMATORY BOWEL DISEASE? PRELIMINARY RESULTS FROM THE FAT-D STUDY

Aysegül Aksan, Corinna Müller, Jürgen Stein, Sami Aksan, Karima Farrag, Oliver Schröder

LOW HAEMOGLOBIN DENSITY (LHD%) AS A NEW BIOMARKER FOR THE DETECTION OF IRON DEFICIENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Karima Farrag

Item 1 - 10 / 16
1
2